INMUNE BIO INC. Accrued Liabilities and Other Liabilities
INMUNE BIO INC. (INMB) had Accrued Liabilities and Other Liabilities of $9.00 thousand as of 2023-06-30, per its 10-Q filed 2023-08-07.
Discontinued › Notes › Payables and Accruals
us-gaap:AccruedLiabilitiesAndOtherLiabilities · last filed 2023-08-07
- 2023-06-30: Accrued Liabilities and Other Liabilities $9.00K.
- 2023-03-31: Accrued Liabilities and Other Liabilities $9.00K.
- 2022-12-31: Accrued Liabilities and Other Liabilities $9.00K.
| Period end | Accrued Liabilities and Other Liabilities |
|---|---|
| 2023-06-30 | $9.00K 10-Q · filed 2023-08-07 |
| 2023-03-31 | $9.00K 10-Q · filed 2023-05-03 |
| 2022-12-31 | $9.00K 10-Q · filed 2023-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |